University of Dundee

Drug Discovery Unit

Short Code: 

School Prizes awarded at Review of the Year

A number of school prizes were presented at Review of the Year today.

Innovator of the Year

New for this year, Innovator of the Year, two categories were introduced for best innovation and for early-stage new business ideas. In partnership with the Centre of Entrepreneurship, the winners are guaranteed an automatic place in the appropriate category of the University of Dundee, Venture 2019 Final, plus a chance to participate in the on-campus three month summer Elevator accelerator programme.

Horn lab challenge trypanosome energy production dogma

Parasitic protozoa called trypanosomes synthesize sugars using an unexpected metabolic pathway called gluconeogenesis, according to a new study published in the open-access journal PLOS Pathogens. The research led by Professor David Horn's team, in particular lead author Dr Julie Kovarova, in collaboration with Professors Mike Ferguson (Dundee) and Mike Barrett (Glasgow) note that this metabolic flexibility may be essential for adaptation to environmental conditions and survival in mammalian host tissues.

Male contraceptive quest boosted by funding from Bill & Melinda Gates Foundation

The quest of researchers at the University of Dundee to develop a new male contraceptive has been boosted with a grant from the Bill & Melinda Gates Foundation. Researchers say the $900,000-plus award will enable significant progress to be made over the next two years in the discovery and development of the first safe and effective male contraceptive drug.

Developing innovative chemistry methodology to efficiently synthesise novel heterocycles as fragments.

Prof Paul Wyatt. Head of the Drug Discovery Unit, and Director of the Wellcome Centre for Anti-Infectives Research, University of Dundee is seeking a highly motivated and enthusiastic synthetic organic or medicinal chemist to carry out a PhD focused on developing innovative chemistry methodology to efficiently synthesise novel heterocycles as fragments. Fragments are low molecular weight and low complexity organic molecules suitable for initiating drug discovery projects.